Occlusin

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameOcclusin
Drug Alias NameOcclusin 50Occlusin 500
ClassificationSmall molecules
Mechanisms of ActionPlatelet aggregation modulators
TargetsUpdating
Therapy Area/IndicationsUterine FibroidsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVirexx Medical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUterine FibroidsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A